Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SHE:301096)

SHE:301096 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	392.89	428.97	881.93	1,239	2,013	133.62
Trading Asset Securities	120	83	-	-	-	-
Cash & Short-Term Investments	512.89	511.97	881.93	1,239	2,013	133.62
Cash Growth	-35.12%	-41.95%	-28.81%	-38.46%	1406.49%	-29.23%
Accounts Receivable	776.82	744.4	532.18	254.49	124.41	63.38
Other Receivables	3.03	3.16	4.1	4.79	4.1	4.87
Receivables	779.86	747.56	536.28	259.28	128.5	68.25
Inventory	197.38	177.34	93.17	66.05	22.85	3.62
Prepaid Expenses	-	-	0.33	1.83	-	-
Other Current Assets	120.31	108.61	96.08	43.94	61.2	33.51
Total Current Assets	1,610	1,545	1,608	1,610	2,226	239.01
Property, Plant & Equipment	1,825	1,832	1,741	1,075	566.63	253.46
Long-Term Investments	192.78	187.78	136.87	81.12	5.77	6.67
Other Intangible Assets	92.48	93.43	92.07	82.37	60.79	62.03
Long-Term Accounts Receivable	-	-	-	1.91	1.95	1.86
Long-Term Deferred Tax Assets	37.14	35.55	48.43	53.41	22.86	10.55
Long-Term Deferred Charges	1.29	1.42	0.25	3.99	14.41	18.25
Other Long-Term Assets	14.31	25.8	43.14	21.6	26.92	47.96
Total Assets	3,774	3,721	3,669	2,930	2,925	639.79
Accounts Payable	119.41	147.36	323.38	167.03	12.64	3.38
Accrued Expenses	19.35	26.95	70.47	44.69	54.8	13.68
Short-Term Debt	530.19	360.08	369.32	-	5.01	19.03
Current Portion of Long-Term Debt	54.41	104.99	-	-	220.32	-
Current Portion of Leases	-	-	0.38	8.84	8.8	-
Current Income Taxes Payable	2.78	10.17	5.06	5.73	6.17	1.72
Current Unearned Revenue	115.99	112.42	74.01	62.61	71.17	50.39
Other Current Liabilities	4.46	7.41	3.56	1.8	93.79	33.5
Total Current Liabilities	846.59	769.38	846.19	290.7	472.69	121.69
Long-Term Debt	244.17	244	-	-	40.44	135.22
Long-Term Leases	3.24	2.92	0.93	-	8.14	-
Long-Term Unearned Revenue	29.54	31.48	40.67	1.45	-	-
Long-Term Deferred Tax Liabilities	-	-	-	4.32	0.01	0.01
Other Long-Term Liabilities	97.18	94.02	97.17	150.97	85.83	42.71
Total Liabilities	1,221	1,142	984.97	447.45	607.1	299.63
Common Stock	109.23	109.23	108.92	108.17	108.17	81.13
Additional Paid-In Capital	2,107	2,107	2,127	2,061	2,026	185.55
Retained Earnings	387.29	413.49	498.68	313.24	183.98	73.51
Treasury Stock	-50	-50	-50	-	-	-
Comprehensive Income & Other	-0.18	-0.14	-0.14	-	-	-
Total Common Equity	2,553	2,579	2,684	2,483	2,318	340.19
Minority Interest	-	-	-	-0.26	-0.14	-0.02
Shareholders' Equity	2,553	2,579	2,684	2,482	2,318	340.17
Total Liabilities & Equity	3,774	3,721	3,669	2,930	2,925	639.79
Total Debt	832.01	711.99	370.64	8.84	282.7	154.24
Net Cash (Debt)	-319.12	-200.02	511.29	1,230	1,730	-20.62
Net Cash Growth	-	-	-58.43%	-28.92%	-	-
Net Cash Per Share	-2.96	-1.86	4.72	11.34	21.34	-0.26
Filing Date Shares Outstanding	109.16	106.15	108.14	108.17	108.17	108.17
Total Common Shares Outstanding	109.16	106.15	108.14	108.17	108.17	81.13
Working Capital	763.84	776.1	761.59	1,319	1,753	117.31
Book Value Per Share	23.39	24.30	24.82	22.95	21.43	4.19
Tangible Book Value	2,461	2,486	2,592	2,400	2,257	278.16
Tangible Book Value Per Share	22.54	23.42	23.97	22.19	20.87	3.43
Buildings	-	-	859.97	196.19	196.14	-
Machinery	-	-	61.76	42.96	319.94	108.62
Construction In Progress	-	-	448.82	546.21	104.08	186.61

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.